NO20074941L - Anvendelse av diosmetinforbindelser i behandlingen og forebyggingen av trombotiske patologier - Google Patents

Anvendelse av diosmetinforbindelser i behandlingen og forebyggingen av trombotiske patologier

Info

Publication number
NO20074941L
NO20074941L NO20074941A NO20074941A NO20074941L NO 20074941 L NO20074941 L NO 20074941L NO 20074941 A NO20074941 A NO 20074941A NO 20074941 A NO20074941 A NO 20074941A NO 20074941 L NO20074941 L NO 20074941L
Authority
NO
Norway
Prior art keywords
prevention
treatment
compounds
diosmetine
pathologies
Prior art date
Application number
NO20074941A
Other languages
English (en)
Norwegian (no)
Inventor
Tony Verbeuren
Michel Wierzbicki
Marie-Francoise Boussard
Alain Rupin
Patricia Sansilvestri-Morel
Marie-Odile Vallez
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20074941L publication Critical patent/NO20074941L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/32—2,3-Dihydro derivatives, e.g. flavanones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20074941A 2005-03-01 2007-10-01 Anvendelse av diosmetinforbindelser i behandlingen og forebyggingen av trombotiske patologier NO20074941L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0502044A FR2882654B1 (fr) 2005-03-01 2005-03-01 Utilisation de derives de la diosmetine pour le traitement et la prevention des pathologies thrombotiques
PCT/FR2006/000441 WO2006092490A1 (fr) 2005-03-01 2006-02-28 Utilisation de derives de la diosmetine pour le traitement et la prevention des pathologies thrombotiques

Publications (1)

Publication Number Publication Date
NO20074941L true NO20074941L (no) 2007-10-01

Family

ID=35134198

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074941A NO20074941L (no) 2005-03-01 2007-10-01 Anvendelse av diosmetinforbindelser i behandlingen og forebyggingen av trombotiske patologier

Country Status (18)

Country Link
US (1) US20080176934A1 (pt)
EP (1) EP1853253A1 (pt)
JP (1) JP2008531660A (pt)
KR (2) KR100971589B1 (pt)
CN (1) CN101132788A (pt)
AR (1) AR053149A1 (pt)
AU (1) AU2006219853B2 (pt)
BR (1) BRPI0607562A2 (pt)
CA (1) CA2599658A1 (pt)
EA (1) EA013078B1 (pt)
FR (1) FR2882654B1 (pt)
MA (1) MA29316B1 (pt)
MX (1) MX2007010364A (pt)
NO (1) NO20074941L (pt)
NZ (1) NZ560749A (pt)
UA (1) UA91848C2 (pt)
WO (1) WO2006092490A1 (pt)
ZA (1) ZA200707472B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2002835A1 (en) 2007-06-04 2008-12-17 GenKyo Tex Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
FR2929276B1 (fr) * 2008-04-01 2010-04-23 Servier Lab Nouveaux derives de diosmetine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
KR101162816B1 (ko) * 2008-04-01 2012-07-09 르 라보레또레 쎄르비에르 디오스메틴 화합물，이의 제조 방법 및 이를 함유하는 약제학적 조성물
EP2165707A1 (en) 2008-09-23 2010-03-24 Genkyo Tex Sa Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
EP2166009A1 (en) 2008-09-23 2010-03-24 Genkyo Tex Sa Pyrazolo pyridine derivatives as nadph oxidase inhibitors
EP2166010A1 (en) 2008-09-23 2010-03-24 Genkyo Tex Sa Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
WO2010062681A2 (en) * 2008-10-30 2010-06-03 University Of South Florida Luteolin and diosmin/diosmetin as novel stat3 inhibitors for treating autism
EP2305679A1 (en) 2009-09-28 2011-04-06 GenKyoTex SA Pyrazoline dione derivatives as nadph oxidase inhibitors
LT2782598T (lt) * 2011-11-23 2020-07-27 In3Bio Ltd. Rekombinantiniai baltymai ir jų terapinis panaudojimas
EP3034500A1 (en) 2014-12-17 2016-06-22 Genkyotex Sa Amido thiazole derivatives as NADPH oxidase inhibitors
CA3017366A1 (en) * 2016-03-11 2017-09-14 H. Lee Moffitt Cancer Center And Research Institute, Inc. Icariin and icaritin derivatives
EP3556385A4 (en) 2016-12-15 2020-12-30 Talengen International Limited PROCESS FOR ALLEGING HEART DISEASE
WO2018107689A1 (zh) * 2016-12-15 2018-06-21 深圳瑞健生命科学研究院有限公司 一种预防和治疗脂质肾损伤的方法
CN108210915A (zh) * 2016-12-15 2018-06-29 深圳瑞健生命科学研究院有限公司 改善心脏病变的药物及其用途
WO2018107690A1 (zh) 2016-12-15 2018-06-21 深圳瑞健生命科学研究院有限公司 一种预防和治疗肥胖症的方法
JP7168990B2 (ja) 2016-12-15 2022-11-10 タレンゲン インターナショナル リミテッド 肥満症を予防および治療するための方法および薬物
CN106822087A (zh) * 2017-01-12 2017-06-13 西南大学 香叶木素在制备治疗ⅱ型糖尿病的药物中的应用
CN109280067B (zh) * 2017-07-21 2022-07-05 南京正大天晴制药有限公司 香叶木苷衍生物、其制备方法以及医药用途
EP3479843A1 (en) 2017-11-01 2019-05-08 GenKyoTex Suisse SA Use of nox inhibitors for treatment of cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2701261B1 (fr) * 1993-02-05 1995-03-31 Adir Nouveaux composés glucuronides de la diosmétine, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
FR2726273B1 (fr) * 1994-10-26 1996-12-06 Adir Nouveaux derives de la diosmetine, leur procede de preparation et les compositions pharmaceutiques les contenant
FR2748025B1 (fr) * 1996-04-25 1998-10-30 Adir Nouveaux acides et esters de la diosmetine, et les compositions pharmaceutiques les contenant
JP2002528540A (ja) * 1998-10-30 2002-09-03 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング ルテオリン及びルテオリン誘導体の製造方法

Also Published As

Publication number Publication date
MX2007010364A (es) 2007-09-25
JP2008531660A (ja) 2008-08-14
MA29316B1 (fr) 2008-03-03
CN101132788A (zh) 2008-02-27
EA013078B1 (ru) 2010-02-26
ZA200707472B (en) 2008-11-26
EP1853253A1 (fr) 2007-11-14
KR20090128581A (ko) 2009-12-15
AR053149A1 (es) 2007-04-25
NZ560749A (en) 2010-11-26
US20080176934A1 (en) 2008-07-24
BRPI0607562A2 (pt) 2009-09-15
FR2882654B1 (fr) 2007-04-27
WO2006092490A1 (fr) 2006-09-08
KR100971589B1 (ko) 2010-07-20
CA2599658A1 (fr) 2006-09-08
UA91848C2 (ru) 2010-09-10
AU2006219853B2 (en) 2011-06-09
EA200701820A1 (ru) 2008-02-28
FR2882654A1 (fr) 2006-09-08
KR20070110395A (ko) 2007-11-16
AU2006219853A1 (en) 2006-09-08

Similar Documents

Publication Publication Date Title
NO20074941L (no) Anvendelse av diosmetinforbindelser i behandlingen og forebyggingen av trombotiske patologier
NO20082594L (no) Pyrimidinylbenzotiofenforbindelser
EA200870019A1 (ru) Лактамовые соединения и способы их применения
NO20081810L (no) Modulatorer av metabolisme og behandling av lidelser relatert dertil
NO20080129L (no) Fremgangsmate for fremstilling av dihydrokinazoliner
MX2007016322A (es) Composiciones y metodos para el diagnostico y tratamiento de tumor.
NO20076515L (no) Hydantoinforbindelser
DK1853602T3 (da) Kemiske forbindelser
CY1108275T1 (el) Χημικες ενωσεις
PH12014500053A1 (en) Proteasome inhibitors
UA100007C2 (ru) Гетероциклические ингибиторы мек, их применение и фармацевтическая композиция, которая их содержит
WO2007137066A3 (en) HETEROCYCLIC INHIBITORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE I AND METHODS OF USING THE SAME
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
GB0625648D0 (en) Compounds
NO20071378L (no) Tiazolo-naftylsyrer.
EP1940437A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF BACTERIA
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
MY140514A (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
IL186217A0 (en) Anti-inflammatory modalities
ZA200800448B (en) Methods and compositions for the prevention and treatment of inflammatory disease
JO3676B1 (ar) مركبات صيدلانية تضم فوكانات معدلة وطرق تتعلق بها
MX2010005714A (es) Compuestos de piridina.
NO20085317L (no) Imidazoazepinonforbindelser
NO20080265L (no) 2-(1H-indolylsulfanyl)-arylaminderivater
CL2008003602A1 (es) Compuestos derivados de triazolotriazinas y triazolopirazinas sustituidas; composicion farmaceutica; y su uso en el tratamiento y/o profilaxis de trastornos hematologicos.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application